Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 2,360 | 2,168 | 1,560 | 1,437 | 1,207 |
| Cost of Goods | 800 | 689 | 397 | 369 | 297 |
| Gross Profit | 1,560 | 1,479 | 1,163 | 1,069 | 910 |
| Operating Expenses | 1,802 | 2,392 | 2,258 | 1,357 | 898 |
| Operating Income | -242 | -912 | -1,094 | -288 | 12 |
| Interest Expense | 6 | 10 | N/A | N/A | N/A |
| Other Income | 247 | 923 | -19 | 6 | 1 |
| Pre-tax Income | N/A | N/A | -1,113 | -282 | 13 |
| Net Income Continuous | -242 | -1,112 | -1,113 | -282 | 13 |
| Net Income | $-242 | $-1,112 | $-1,113 | $-282 | $13 |
| EPS Basic Total Ops | -0.01 | -0.03 | -0.03 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.03 | -0.03 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.01 | -0.03 | -0.03 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.03 | -0.03 | -0.01 | 0.00 |
| EBITDA(a) | $-66 | $-733 | $-927 | $-123 | $124 |